{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Gly",
          "alt": "Asp",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations of the mitochondrial PTEN (phosphatase and tensin homologue)induced kinase1 (PINK1) are important causes of recessive Parkinson disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, linking PINK1 mutations to PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Using fruit fly and mouse models we show that PINK1 deficiency or clinical mutations impact on the function of Complex I of the mitochondrial respiratory chain, resulting in mitochondrial depolarization and increased sensitivity to apoptotic stress in mammalian cells and tissues.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (respiratory chain function assay) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Mitochondrial oxygen consumption assays were performed in the presence of 5 mM glutamate/2.5 mM malate for the analysis of Complex I-driven respiration; 5 mM succinate in the presence of 2 mM rotenone for Complex II-driven respiration; or 3 mM ascorbate plus 150 mM TMPD in the presence of 0.5 mg/ml antimycin A for Complex IV-driven respiration.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of controls and replicates for the experiments, indicating a robust experimental design.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Human PINK1 (hPink1 res ) fully complemented Complex I enzymatic activity in Pink1 À/À mouse fibroblasts. In contrast, two PD PINK1 clinical mutations G309D (Gly 309 ! Asp) and W437X (Trp 437 ! Xxx) as well as an artificial mutation K219A (Lys 219 ! Ala) that inactivates the kinase domain(Silvestri et al, 2005) were not effective.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used in the assay, including known pathogenic variants and an artificial mutant, supporting the validity of the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Statistical analysis was performed using the unpaired Student's t-test, where Ã p ¼ 0.03, ÃÃ p < 0.005 and ÃÃÃ p ¼ 0.00006 when compared to wild-type (Graph Pad Prism5 software).",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical analyses supporting the findings, though OddsPath is not directly calculated.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The PINK1 G309D variant shows a significant impact on Complex I function, supported by robust experimental evidence and statistical analysis, warranting a moderate strength pathogenic evidence rating."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "Trp",
          "alt": "Xxx",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations of the mitochondrial PTEN (phosphatase and tensin homologue)induced kinase1 (PINK1) are important causes of recessive Parkinson disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant, linking PINK1 mutations to PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Using fruit fly and mouse models we show that PINK1 deficiency or clinical mutations impact on the function of Complex I of the mitochondrial respiratory chain, resulting in mitochondrial depolarization and increased sensitivity to apoptotic stress in mammalian cells and tissues.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (respiratory chain function assay) effectively models the disease pathogenesis/mechanism defined in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Mitochondrial oxygen consumption assays were performed in the presence of 5 mM glutamate/2.5 mM malate for the analysis of Complex I-driven respiration; 5 mM succinate in the presence of 2 mM rotenone for Complex II-driven respiration; or 3 mM ascorbate plus 150 mM TMPD in the presence of 0.5 mg/ml antimycin A for Complex IV-driven respiration.",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of controls and replicates for the experiments, indicating a robust experimental design.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Human PINK1 (hPink1 res ) fully complemented Complex I enzymatic activity in Pink1 À/À mouse fibroblasts. In contrast, two PD PINK1 clinical mutations G309D (Gly 309 ! Asp) and W437X (Trp 437 ! Xxx) as well as an artificial mutation K219A (Lys 219 ! Ala) that inactivates the kinase domain(Silvestri et al, 2005) were not effective.",
          "judgment": "Yes",
          "reasoning": "Variant controls were used in the assay, including known pathogenic variants and an artificial mutant, supporting the validity of the assay.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Statistical analysis was performed using the unpaired Student's t-test, where Ã p ¼ 0.03, ÃÃ p < 0.005 and ÃÃÃ p ¼ 0.00006 when compared to wild-type (Graph Pad Prism5 software).",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical analyses supporting the findings, though OddsPath is not directly calculated.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_moderate / Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The PINK1 W437X variant demonstrates a significant impact on Complex I function, with experimental evidence and statistical support, leading to a moderate strength pathogenic evidence rating."
    }
  ]
}